Maxcyte (MXCT) Depreciation & Amortization (CF) (2020 - 2026)
Maxcyte (MXCT) posted quarterly Depreciation & Amortization (CF) of $1.0 million for Q1 2026, down 4.47% year-over-year from $1.1 million in Q1 2025, and down 2.33% quarter-over-quarter from $1.1 million in Q4 2025.
Maxcyte (MXCT) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends
Maxcyte (MXCT) has reported Depreciation & Amortization (CF) for 7 consecutive years, with $1.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) fell 4.47% year-over-year to $1.0 million; the TTM figure through Mar 2026 stood at $4.3 million (changed 0.21% YoY), while the FY2025 annual figure was $4.3 million, up 0.58% from the prior year.
- Depreciation & Amortization (CF) retreated to $1.0 million in Q1 2026 per MXCT's latest filing, from $1.1 million in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $1.1 million in Q1 2024 and bottomed at $487400.0 in Q1 2022.
- Historically, Depreciation & Amortization (CF) has averaged $974752.9 across 5 years, with a median of $1.1 million in 2024.
- Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) soared 120.82% — and 2026, when it decreased 4.47%.
- Maxcyte's Depreciation & Amortization (CF) stood at $919700.0 in 2022, then gained by 19.82% to $1.1 million in 2023, then slipped by 4.08% to $1.1 million in 2024, then increased by 1.42% to $1.1 million in 2025, then decreased by 2.33% to $1.0 million in 2026.
- Business Quant data shows MXCT's Depreciation & Amortization (CF) at $1.0 million in Q1 2026, $1.1 million in Q4 2025, and $1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.52 Bn | 193.92 Bn | 7.27 Bn | - |
| 2 | Stryker | 129.55 Bn | 126.07 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.60 Bn | 110.38 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 73.64 Bn | 73.10 Bn | 3.85 Bn | 355.00 Mn |
| 5 | Edwards Lifesciences | 52.33 Bn | 48.08 Bn | 1.35 Bn | 42.70 Mn |
| 6 | Dexcom | 34.69 Bn | 32.74 Bn | 830.00 Mn | 68.20 Mn |
| 7 | GE HealthCare Technologies | 34.10 Bn | 31.99 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn | 750.89 Mn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | 123.80 Mn |
| 10 | Maxcyte | 147.95 Mn | 147.95 Mn | 5.60 Mn | 978,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 978,000.00 |
| Jun 30, 2026 | 978,000.00 |
| Mar 31, 2026 | 1.05 Mn |
| Mar 31, 2026 | 1.05 Mn |
| Dec 31, 2025 | 1.07 Mn |
| Dec 31, 2025 | 1.07 Mn |
| Sep 30, 2025 | 1.07 Mn |
| Sep 30, 2025 | 1.07 Mn |
| Jun 30, 2025 | 1.10 Mn |
| Jun 30, 2025 | 1.10 Mn |
| Mar 31, 2025 | 1.10 Mn |
| Mar 31, 2025 | 1.10 Mn |
| Dec 31, 2024 | 1.06 Mn |
| Dec 31, 2024 | 1.06 Mn |
| Sep 30, 2024 | 1.07 Mn |
| Sep 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | 1.08 Mn |
| Jun 30, 2024 | 1.08 Mn |
| Mar 31, 2024 | 1.11 Mn |
| Mar 31, 2024 | 1.11 Mn |